相关实验视频

Updated: Jan 15, 2026

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat

Published on: February 4, 2021

巨细胞作为性大动脉膜疾病的关键调节剂

Nervana Issa¹, Gérémy Blot¹, Alexandre Candellier¹

¹UR UPJV 7517, MP3CV, CURS, Amiens, France.

Frontiers in cardiovascular medicine

|October 10, 2025

概括

巨细胞在常见的心脏病 - - 状大动脉病 (CAVD) 中起着双重作用. 了解它们复杂的功能是开发大动脉狭窄症 (AS) 新疗法的关键.

科学领域:

心血管生物学心血管生物学
免疫学免疫学免疫学
翻译医学是一种翻译医学.

背景情况:

动脉疾病 (CAVD) 是最常见的膜性心脏病,其特点是动脉 (AV) 传单重塑导致动脉狭窄 (AS).
目前对AS的治疗方法有限,门置换是标准干预措施.
巨细胞,具有高可塑性的免疫细胞,越来越多地被认为是CAVD病变发生的关键参与者,影响门重塑.

研究的目的:

审查不同巨细胞子集在CAVD中AV改造的发展,进展和潜在逆转中的多方面的作用.
探索向巨细胞功能的治疗潜力,以管理AS.

主要方法:

本综述综合了CAVD的背景下对巨细胞生物学的当前研究.
它检查了巨细胞促进或抑制AV化,纤维化和矿物化的机制.
该审查还考虑了巨细胞在原生门和生物假体门中的参与.

主要成果:

炎症性巨细胞通过释放像BMP2这样的亲骨质原因子和促进氧化应激来促进CAVD.
免疫调节性巨细胞可以通过抑制化来提供保护,但矛盾的是,通过亲纤维素因子分泌和骨髓细胞转化为介质酶的过渡来促进纤维化.
在AV中的巨细胞可以采用类似骨质细胞的表型,这表明门内的骨类重塑过程.

结论:

巨细胞的表型可塑性复杂化了CAVD的发病过程,需要对它们多样化的功能有更深入的了解.
准特定的巨细胞子组或其活动是减缓AS进展的有希望的治疗策略.
对巨细胞可塑性的进一步研究对于开发有效的CAVD预防和治疗干预措施至关重要.

关键词:

大动脉门的大动脉门甲状腺膜疾病甲状腺膜疾病化的化过程有纤维化的纤维化.这是一种炎症炎症炎症炎症.巨细胞是什么?巨细胞是什么?

更多相关视频

Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro

Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro

Published on: May 10, 2021

Isolation of Human Primary Valve Cells for In vitro Disease Modeling

Isolation of Human Primary Valve Cells for In vitro Disease Modeling

Published on: April 16, 2021

相关概念视频

Inflammation

Inflammation

Aortic Regurgitation III: Medical Management

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...